| HOME >> BIOLOGY >> TECHNOLOGY |
Boston based strategic market research firm expands its presence in Europe
and deepens its methodological expertise.
BOSTON, April 7, 2008 /PRNewswire/ -- The company is pleased to announce the appointment of Penny Mesure as a Director based in the United Kingdom. Penny will work closely with US colleagues to support and facilitate the continuing expansion of the company's European and global business. Penny specializes in the provision of actionable insight to research managers, while working in strategic partnership with C- Suite Executives to help them better understand their ROI from Marketing Budgets. Her recent clients have been both EU- and US-based, with an emphasis on pharmaceuticals, healthcare, and applied technologies. Her consulting focus has included Brand Positioning and the evaluation of integrated communications, including PR and new media. Penny graduated from Cambridge University with a background in Neuroscience. She helped pioneer the Market Research Society's Professional Development Scheme in the UK and is a Member of the MRS Conference Awards Panel. Penny says: "Over the years I have helped many clients gain competitive advantage and drive their businesses forward. I believe passionately in rigorous research methodology but this is just a starting point. The key lies in addressing the 'so what?' and the 'now what?' questions and aiding clients in taking indicated action."
(Logo: http://www.newscom.com/cgi-bin/prnh/20070913/NETH094LOGO )
The firm is also pleased to appoint Lana Limpert as a Director, leveraging her experience as senior qualitative research specialist. Lana has designed, managed, and moderated custom qualitative studies for major pharmaceutical and biotech companies for many years. Her background includes a dozen years as principal of her own consultancy, TechniClarity and 10 years of training as an Ericksonian hypnotherapist. Lana's qualitative expertise includes emotional mining research, innovative projective techniques, and moderation of sensitive topics. "To understand what underlies the differences between people's rational thinking and how they make choices, to draw them out and learn about their attitudes, perceptions, attitudes and behaviors is endlessly fascinating and a privilege," says Limpert. "Observant LLC values the power of qualitative research and the important role it plays in our clients' businesses. In my new role, I will continue to push the envelope of qualitative research excellence." Committed to sharing her business and research knowledge, Lana is current feature editor and past Editor-in-Chief of QRCA Views, and she enthusiastically invests in training and mentoring qualitative researchers. Lana has a Master's of Liberal Studies degree from State University of New York, Brockport.
Observant LLC is a strategic market research partner to the pharmaceutical and biotechnology industries worldwide. The firm offers a full spectrum of research and consulting services including analytically sophisticated quantitative studies and best-in-class qualitative research studies. Observant LLC supports its clients by conducting research in North America, Europe, Asia, South America, and Australia. Observant LLC principals and personnel have cross-industry backgrounds in consulting and public health and have published extensively on research methods and health science. For more information about the company please visit: http://www.observant.biz.
'/>"/>
| SOURCE Observant LLC Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Observant LLC Expands Senior Management Team
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |